Co-Therapy of Silymarin and Vitamin E Attenuates Doxorubicin-Induced Hepatotoxicity in Rats by Mitigating Oxidative Damage and Preserving Hepatic Architecture. (2026). Tikrit Journal of Pharmaceutical Sciences, 20(1), 20-32. https://doi.org/10.25130/tjphs.2026.20.1.3.20.32